Manuscript Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s AssociationStudy adds further validation that Annovis’ lead compound is […]
Acquisition to support accelerated commercialization of Koligo’s KYSLECEL®, a personalized islet cell therapy available in the U.S. for chronic and recurrent […]
Heidelberg, Germany, September 29, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate […]